Journal of Clinical Epidemiology
Volume 53, Issue 11 , Pages 1158-1163 , November 2000

Estimating the prevalence of hypertension corrected for the effect of within-person variability in blood pressure

  • Olaf H Klungel

      Affiliations

    • Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute of Pharmaceutical Sciences (UIPS), Utrecht University, Sorbonnelaan 16, 3584 CA, Utrecht, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31 30 253 73 24; fax: +31 30 253 91 66.
    • ,
  • Anthonius de Boer

      Affiliations

    • Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute of Pharmaceutical Sciences (UIPS), Utrecht University, Sorbonnelaan 16, 3584 CA, Utrecht, The Netherlands
    • ,
  • Arsenio H.P Paes

      Affiliations

    • Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute of Pharmaceutical Sciences (UIPS), Utrecht University, Sorbonnelaan 16, 3584 CA, Utrecht, The Netherlands
    • ,
  • Nico J.D Nagelkerke

      Affiliations

    • Department of Chronic Diseases Epidemiology, National Institute of Public Health and the Environment, Bilthoven, The Netherlands
    • ,
  • Jacob C Seidell

      Affiliations

    • Department of Chronic Diseases Epidemiology, National Institute of Public Health and the Environment, Bilthoven, The Netherlands
    • ,
  • Albert Bakker

      Affiliations

    • Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute of Pharmaceutical Sciences (UIPS), Utrecht University, Sorbonnelaan 16, 3584 CA, Utrecht, The Netherlands

Received 6 April 1999 ,Revised 9 February 2000 ,Accepted 10 February 2000.

References 

  1. Sempos CT, Looker AC, Johnson CL, Woteki CE. The importance of within-person variability in estimating prevalence. In:  Willett WC editors. Nutritional Epidemiology. Oxford: Oxford University Press; 1990;p. 99–109
  2. Strachan D, Rose G. Strategies of prevention revisited (effects of imprecise measurement of risk factors on the evaluation of “high-risk” and “population-based” approaches to prevention of cardiovascular disease). J Clin Epidemiol. 1991;40:1187–1196
  3. Birkett NJ. The effect of alternative criteira for hypertension on estimates of prevalence and control. J Hypertens. 1997;15:237–244
  4. Armitage P, Fox W, Rose GA, Tinker CM. The variability of measurements of casual blood pressure. II. Survey experience. Clin Sci. 1966;30:337–344
  5. Klungel OH, de Boer A, Paes AHP, Seidell JC, Bakker A. Influence of correction for within-person variability on the prevalence estimation of hypertension, treatment, and undertreatment of hypertension. Pharmacoepidemiology and Drug Safety. 1997;6(suppl. 2):S25;(abstr)
  6. The Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure . The Fifth Report of the National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med. 1993;153:154–183
  7. Guidelines Sub-Committee of the WHO/ISH Mild Hypertension Liason Committee . 1993 Guidelines for the management of mild hypertension (memorandum from a World Health Organization/International Society of Hypertension meeting). J Hypertens. 1993;11:905–918
  8. Looker AC, Sempos CT, Liu K, Johnson CL, Gunter EW. Within-person variance in biochemical indicators of iron status (effects on prevalence estimates). Am J Clin Nutr. 1990;52:541–547
  9. Burt Vl, Cutler JA, Higgins M, Horan MJ, Labarthe D, Whelton P, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the Health Examination Surveys, 1960 to 1991. Hypertension. 1995;26:60–69
  10. The WHO MONICA Project . Geographical variation in the major risk factors of coronary heart disease in men and women aged 35–64 years. Wld Hlth Statist Quart. 1988;41:115–139
  11. Verschuren WMM, van Leer EM, Blokstra A, Seidell JC, Smit HA, Bueno de Mesquita HB, et al. Cardiovascular disease risk factors in The Netherlands. Neth J Cardiol. 1993;4:205–210
  12. Wilson PD. Correcting for selection bias in estimation of within-individual variance. Stat Med. 1988;7:417–422
  13. Smith L, Rosner B. Estimation of variance components of censored data with applications to blood pressure variability. Stat Med. 1991;10:1441–1452
  14. Shepard DS. Reliability of blood pressure measurements (implications for designing and evaluating programs to control hypertension). J Chron Dis. 1981;34:191–209
  15. Rosner B, Polk BF. Predictive values of routine blood pressure measurements in screening for hypertension. Am J Epidemiol. 1983;117:429–442
  16. Kleinbaum DG, Kupper LL, Muller KE. Applied regression analysis and other multivariable methods. Belmont, CA: Duxbury Press; 1988;
  17. Miettinen OS. Estimation of relative risk from individually matched series. Biometrics. 1970;26:75–86
  18. Hebel JR, Apostolides AY, Dischinger P, Entwisle G, Su S. Within-person variability in diastolic blood pressure for a cohort of normotensives. J Chron Dis. 1980;33:745–750
  19. Rosner B, Polk BF. The implications of blood pressure varability for clinical and screening purposes. J Chron Dis. 1979;32:451–461
  20. Cook NR, Scherr PA, Evans DA, Laughlin LW, Chapman WG, Rosner B, et al. Regression analysis of changes in blood pressure with oral contraceptive use. Am J Epidemiol. 1985;121:530–540
  21. Hughes MD, Pocock SJ. Within-subject diastolic blood pressure variability (implications for risk assessment and screening). J Clin Epidemiol. 1992;45:985–998
  22. Writing committee on behalf of the HDFP cooperative group . Variability of blood pressure and the results of screening in the hypertension detection and follow-up program. J Chron Dis. 1978;31:651–667
  23. Rose GA, Holland WW, Crowley EA. A sphygmomanometer for epidemiologists. Lancet. 1964;I:296

PII: S0895-4356(00)00228-6

Journal of Clinical Epidemiology
Volume 53, Issue 11 , Pages 1158-1163 , November 2000

Article Tools